Today: 5 July 2026
Browse Category

NASDAQ:TELO 21 November 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals shares react to new preclinical leukemia data and a director resignation on November 21, 2025. Here’s what today’s Telomir-1 news means for TELO stock and investors. On Friday, November 21, 2025, Telomir Pharmaceuticals, Inc., a Miami‑based preclinical biotech focused on small‑molecule therapies for cancer, aging and age‑related disease, released a new press release highlighting fresh in‑vitro data in human leukemia cells. Finanznachrichten
21 November 2025
··

Stock Market Today

  • iShares 20+ Year U.S. Treasury Bond ETF (XTLH:CA) trading signals for July 5
    July 5, 2026, 5:10 AM EDT. AI trading signals for iShares 20+ Year U.S. Treasury Bond Index ETF (CAD-Hedged) (XTLH:CA) as of July 5, 2026 give a weak near-term rating, and neutral mid- and long-term ratings. Trade ideas are to buy near CAD 31.66 with CAD 33.39 as a target and a CAD 31.50 stop, or to short close to CAD 33.39 aiming for CAD 31.66 with a stop loss at CAD 33.56. The fund follows U.S. Treasury bonds, hedged to Canadian dollars. These ratings and levels speak to short-term volatility for this update.
Go toTop